Sector Watch: Healthcare - May 21 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $106.38 -1.42 -1.32% | XBI: $91.78 -1.78 -1.9% | Updated May 21, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| TRXC TransEnterix $649.5M |
3.43+0.39 12.4 M 4.4x |
13% | ||
| GEN Genesis Healthcare $301.6M |
1.99+0.17 1.2 M 2.4x |
9% | ||
| XTNT Xtant Medical Holdings $83.8M |
6.41+0.51 367.4 K 18.2x |
9% | ||
| FMI52WH Foundation Medicine $3.2B |
87.00+5.90 338.1 K |
7% | ||
| ATEC Alphatec Holdings $101.9M |
3.99+0.26 111.8 K |
7% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| NBRV Nabriva Therapeutics AG $218.9M |
4.53-0.90 9.3 M 33.3x |
-17% | ||
| ABEO Abeona Therapeutics $758.1M |
16.02-2.85 3.2 M 2.9x |
-15% | ||
| EVFM Evofem BioSciences $83.6M |
4.70-0.70 49.3 K 2.9x |
-13% | ||
| QHC Quorum Health $129.3M |
4.50-0.61 1.0 M 2.0x |
-12% | ||
| OASM Oasmia Pharmaceutical AB $84.7M |
1.33-0.18 6.4 K |
-12% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Quorum Health Corporation Announces Leadership Transition | Business Wire [businesswire.com]Foundation Medicine Receives New ADLT Status for FoundationOne CDx? from the Centers for Medicare and Medicaid Services (CMS) | Business Wire [businesswire.com]
Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc. [globenewswire.com]
Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting [globenewswire.com]
Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting [globenewswire.com]
Results from Oasmia Pharmaceutical?s phase III study will be presented at ASCO annual meeting in June [globenewswire.com]
Notification from Oasmia Pharmaceutical [globenewswire.com]
Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
